← The Wire
BCRXNasdaq
BIOCRYST PHARMACEUTICALS INC
Biological Products, (No Diagnostic Substances) · DE · CIK 882796
Biocryst Pharmaceuticals develops and commercializes medicines for rare diseases like HAE
red 8-K · 90d
$2.21B
Market cap
$9.55
Last close
-3.9%
1D
+4.5%
5D
6.5M
Volume
Price · last 39 sessions+3.8%
May 4L $8.19 · H $10.00Jun 29
340
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-KExit / Disposal Costs · Reg FD DisclosureJun 29, 20268-KExecutive Change · Shareholder VoteJun 12, 202610-Q10-QMay 6, 20268-KResults of Operations · Reg FD DisclosureMay 6, 20268-KReg FD DisclosureMay 4, 2026DEFA14ADEFA14AApr 23, 2026DEF 14ADEF 14AApr 23, 202610-K10-KFeb 26, 20268-KResults of Operations · Reg FD DisclosureFeb 26, 20268-K/AExecutive ChangeJan 23, 20268-KMaterial Agreement · Acquisition / DispositionJan 23, 20268-KResults of Operations · Reg FD DisclosureJan 12, 20268-KReg FD DisclosureJan 9, 20268-KCompany UpdateDec 12, 20258-KExecutive ChangeDec 11, 2025425425Dec 3, 20258-KCompany UpdateDec 3, 2025S-4S-4Nov 20, 202510-Q10-QNov 4, 20258-KResults of Operations · Reg FD DisclosureNov 3, 2025425425Oct 14, 2025425425Oct 14, 2025425425Oct 14, 2025425425Oct 14, 20258-KExecutive Change · Material AgreementOct 14, 20258-KMaterial Agreement · Company UpdateOct 1, 20258-KExecutive ChangeAug 11, 202510-Q10-QAug 5, 20258-KResults of Operations · Reg FD DisclosureAug 4, 20258-KExecutive Change · Reg FD DisclosureJul 31, 20258-KExecutive Change · Reg FD DisclosureJul 7, 20258-KMaterial AgreementJun 30, 20258-KCompany UpdateJun 27, 20258-KCompany UpdateJun 25, 20258-KExecutive Change · Shareholder VoteJun 16, 20258-KExecutive ChangeJun 4, 20258-KCompany UpdateMay 14, 202510-Q10-QMay 6, 20258-KResults of Operations · Reg FD DisclosureMay 5, 20258-KExecutive ChangeMay 1, 2025DEFA14ADEFA14AApr 24, 2025DEF 14ADEF 14AApr 24, 20258-KExecutive ChangeApr 10, 20258-KCompany UpdateMar 11, 20258-KExecutive ChangeMar 4, 202510-K10-KFeb 25, 20258-KResults of Operations · Reg FD DisclosureFeb 24, 20258-KReg FD DisclosureJan 13, 20258-KResults of Operations · Reg FD DisclosureJan 10, 20258-KReg FD DisclosureJan 8, 202510-Q10-QNov 5, 20248-KResults of Operations · Reg FD DisclosureNov 4, 20248-KReg FD DisclosureOct 2, 20248-KReg FD Disclosure · Company UpdateSep 30, 202410-Q10-QAug 6, 20248-KResults of Operations · Reg FD DisclosureAug 5, 20248-KExecutive Change · Shareholder VoteJun 13, 202410-Q10-QMay 7, 20248-KResults of Operations · Reg FD DisclosureMay 6, 2024DEFA14ADEFA14AApr 25, 2024DEF 14ADEF 14AApr 25, 202410-K10-KFeb 27, 20248-KResults of Operations · Reg FD DisclosureFeb 26, 2024SC 13GBIOCRYST PHARMACEUTICALS INC.Feb 14, 20248-KBylaw AmendmentJan 18, 20248-KResults of Operations · Reg FD DisclosureJan 8, 20248-KExecutive ChangeDec 1, 20238-KReg FD DisclosureNov 30, 202310-Q10-QNov 8, 20238-KReg FD DisclosureNov 3, 20238-KReg FD DisclosureNov 3, 20238-KResults of Operations · Reg FD DisclosureNov 2, 20238-KReg FD DisclosureOct 26, 202310-Q10-QAug 7, 20238-KResults of Operations · Reg FD DisclosureAug 3, 20238-KExecutive ChangeJul 11, 20238-KExecutive Change · Shareholder VoteJun 14, 202310-Q10-QMay 8, 20238-KResults of Operations · Reg FD DisclosureMay 3, 2023DEFA14ADEFA14AApr 27, 2023
Insider Activity
In the 90 days to Mar 20, 2026: 2 sold $2.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 20, 2026 | Heggie TheresaDirector | Sell | 49,933 | $10.11 | $505K |
| Mar 16, 2026 | Barnes Alane PChief Legal Officer | Sell | 150,000 | $9.15 | $1.4M |
| Dec 22, 2025 | Barnes Alane PChief Legal Officer | Sell | 21,773 | $7.65 | $167K |
| Dec 15, 2025 | Barnes Alane PChief Legal Officer | Sell | 21,210 | $7.65 | $162K |
| Dec 3, 2025 | Barnes Alane PChief Legal Officer | Sell | 19,770 | $7.65 | $151K |
| Dec 2, 2025 | Barnes Alane PChief Legal Officer | Sell | 50,906 | $7.21 | $367K |
| Dec 1, 2025 | Barnes Alane PChief Legal Officer | Sell | 91,004 | $7.10 | $646K |
| Nov 13, 2025 | Sanders MachelleDirector | Sell | 9,600 | $7.14 | $69K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance